Surgery – Blood vessel or graft preparation
Reexamination Certificate
2006-12-05
2010-02-09
Gilbert, Samuel G (Department: 3735)
Surgery
Blood vessel or graft preparation
Reexamination Certificate
active
07658706
ABSTRACT:
The present technology is related to the field of sterilization and decellularization of allografts or xenografts, specifically to processes that achieve effective removal of the cells contained within a vascular tissue matrix and an effective reduction in potential harmful organisms to create grafts suitable for human implantation. In some embodiments, vascular grafts, vascular tissue and/or blood vessels are contacted with cleaning solution under conditions suitable conditions to reduce immune reaction in patients. More specifically, the present technology is directed to sterilization and decellularization of vascular grafts.
REFERENCES:
patent: 4144744 (1979-03-01), Hill
patent: 5415619 (1995-05-01), Lee et al.
patent: 5460962 (1995-10-01), Kemp
patent: 5792603 (1998-08-01), Dunkelman et al.
patent: 5890489 (1999-04-01), Elden
patent: 5899936 (1999-05-01), Goldstein
patent: 5993844 (1999-11-01), Abraham et al.
patent: 5997575 (1999-12-01), Whitson et al.
patent: 6121042 (2000-09-01), Peterson et al.
patent: 6312474 (2001-11-01), Francis et al.
patent: 6334872 (2002-01-01), Termin et al.
patent: 6432712 (2002-08-01), Wolfinbarger, Jr.
patent: 6482584 (2002-11-01), Mills et al.
patent: 6509145 (2003-01-01), Torrianni
patent: 6533767 (2003-03-01), Johansson et al.
patent: 6561970 (2003-05-01), Carpentier et al.
patent: 6572650 (2003-06-01), Abraham et al.
patent: 6689161 (2004-02-01), Chen et al.
patent: 6734018 (2004-05-01), Wolfinbarger, Jr. et al.
patent: 6866686 (2005-03-01), Ollerenshaw et al.
patent: 6878168 (2005-04-01), Carpentier et al.
patent: 6893653 (2005-05-01), Abraham et al.
patent: 7008763 (2006-03-01), Cheung
patent: 2003/0027125 (2003-02-01), Mills et al.
patent: 2003/0180268 (2003-09-01), Atala
patent: 2003/0219417 (2003-11-01), Wolfinbarger
patent: 2004/0076657 (2004-04-01), Wolfinbarger et al.
patent: 2005/0203636 (2005-09-01), McFetridge
Demasi, R.J. and S.O. Snyder, The current status of prosthetic-vein composite grafts for lower extremity revascularization. Surg Clin North Am, 1995. 75(4): p. 741-52.
Benedetti-Valentini, F., Gossetti , B., Irace, I., Martinelli, O., Gattuso, R., Composite grafts for critical ischemia. Cardio Vasc Surg, 1996. 4(3): p. 372-376.
Delaurentis, D., Freidmann, P, Arterial reconstruction about and below the knee: another look. Am J Surg, 1971. 121(April): p. 392-397.
Linton, R.R., Wirthlin, L.S., Femoropopliteal composite Dacron and autogenous vein bypass grafts. Arch Surg, 1973. 107: p. 748-753.
Promotion, N.C.f.C.D.P.a.H., Diabetes: Disabling, Deadly, and on the Rise. 2002, Centers for Disease Control and Prevention.
Hepatitis C virus transmission from an antibody negative organ and tissue donor—United States, 2000-2002. MMWR Weekly, 2003. 52(13): p. 273-276.
Silverstein, R.L., The Vascular Endothelium, in Inflammation: Basic Principles and Clinical Correlates, J.I. Gallin and R. Snyderman, Editor. 1999, Lippincott Williams & Wilkins: Philadelphia. p. 207-225.
Allaire, E., et al., Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg, 1994. 19(3): p. 446-56.
Madden, R., et al., Decellularized cadaver vein allografts used for hemodialysis access do not cause allosensitization or preclude kidney transplantation. Am J Kidney Dis, 2002. 40(6): p. 1240-3.
Kasimir, M.T., et al., Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs, 2003. 26(5): p. 421-7.
Block, S.S., Disinfection, Sterilization, and Preservation. Fifth ed. 2001, Philadelphia: Lippincott Williams & Wilkins.
Guidance on the Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Germicides, U.S.D.o.H.a.H. Services, Editor. 1996.
Kenyon, D.E., A mathematical model of water flux through aortic tissue. Bull Math Biol, 1979. 41(1): p. 79-90.
Wang, D.M. and J.M. Tarbell, Modeling interstitial flow in an artery wall allows estimation of wall shear stress on smooth muscle cells. J Biomech Eng, 1995. 117(3): p. 358-63.
Conte, M.S., The ideal small arterial substitute: a search for the Holy Grail? Faseb J, 1998. 12(1): p. 43-5.
Conklin, B.S., et al., Development and evaluation of a novel decellularized vascular xenograft. Med Eng Phys, 2002. 24(3): p. 173-83.
Stillman, R.M., Excerpt from infrainguinal occlusive disease, eMedicine.
Prager, M., Holzenbein, T., Aslim, E., Domenig, C., Muhlbacher, F., Kretschmer, G., Fresh arterial homograft transplantation: a novel concept for critical limb ischemia. Eur J Vasc Endovasc Surg, 2002. 24: p. 314-321.
Timaran, C., Goldman, MH, Saphenous vein allografts for infrainguinal arterial reconstruction: current role as vascular conduits. Adv Vasc Surg, 2002. 10: p. 183-197.
Bader, A., et al., Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation, 2000. 70(1): p. 7-14.
Administration, U.S.F.a.D., Human Cells, Tissues, and Cellular and Tissue-Based Products. 2004.
Bastounis, E., et al., PTFE-vein composite grafts for critical limb ischaemia: a valuable alternative to all-autogenous infrageniculate reconstructions. Eur J Vasc Endovasc Surg, 1999. 18(2): p. 127-32.
Lord, J.W., Jr., et al., New technique for construction of coposite Dacron vein grafts for femoro-distal popliteal bypass in the severely ischemic leg. Ann Surg, 1975. 181(5): p. 670-5.
Oppat, W.F., et al., Natural history of composite sequential bypass: ten years' experience. Arch Surg, 1999. 134(7): p. 754-7; discussion 757-8.
Promotion, N.C.f.C.D.P.a.H., 1999 Diabetes Surveillance Report. 1999, Centers for Disease Control and Prevention.
Alexander, J.J., Wells, K.E., Yuhas, J.P., Piotrowski, J.J., The role of composite sequential bypass in the treatment of multilevel infrainquinal arterial occlusive disease. Am J Surg, 1996. 172: p. 118-122.
Castier, Y., et al., Early experience with cryopreserved arterial allografts in below-knee revascularization for limb salvage. Am J Surg, 1999. 177(3): p. 197-202.
Faries, P.L., Logerfo, F.W., Arora, S., Pulling, M.C., Rohan, D. I., Akbari, C.M., Campbell, D.R., Gibbons, G.W., Pomposelli, F.B., Arm vein conduit is superior to composite prosthetic-autogenous grafts in lower extremity revasculariztion. J Vasc Surg, 2000. 31(6): p. 1119-1126.
Londrey, G.L., Ramsey, D.E., Hodgson, K.J., Barkmeier, L.D., Sumner, D.S., Infrapopliteal bypass for severe ischemia: comparison of autogenous vein, composite, and prosthetic grafts. J Vasc Surg, May 1991. 13(5): p. 631-636.
Fung, Y.C. and S.Q. Liu, Determination of the mechanical properties of the different layers of blood vessels in vivo. Proc Natl Acad Sci U S A, 1995. 92(6): p. 2169-73.
McClurken, M., Lipson, D., Collagen shrinkage and vessel sealing. 2001, TissueLink Medical, Inc.: Dover.
Gupta, B.S., Kasyanov, V.A., Biomechanics of human common carotid artery and design of novel hybrid textile compliant vascular grafts. J Biomed Mater Res., 1997. 34(3): p. 341-349.
Gabriel, M., Kostrzewa, A., Sobieska, M., Immune response after cryopreserved aortic allograft replacement for major vascular infection. Transplant Proceedings, 2002. 34: p. 713-714.
Bowman, F.O., et al., Further evaluation of aortic valve homografts sterilized by electron-beam energy. Circulation, 1969. 39(supp I): p. 57-60.
Control, C.f.D., Update: allograft-associated bacterial infections—United States. MMWR Weekly Report, 2002. 51: p. 207-210.
Invasive Streptococcus pyogenes after allograft implantation—Colorado, 2003. MMWR Weekly, 2003. 52(48): p. 1173-1176.
Reller, L.B., et al., Bacterial endocarditis caused by Oerskovia turbata. 1975. 83(5): p. 664-666.
Pukacki, F., et al., The mechanical properties of fresh and cryopreserved arterial homografts. Eur J Vasc Endovasc Surg, 2000. 20(1): p. 21-4.
Bellon, J.M., et al., Arterial damage induced by cryopreservation is irreversible following organ culture. Eur J Vasc Endovasc Surg, 1999. 17(2): p. 136-43.
Galambos, B., et al., Preservation of vein allograft viability during long-term storage. Eur Surg Res, 2005. 37(1): p. 60-7.
Pascual, G., et al., Effect of the thawing process
Gilbert Samuel G
McAndrews Held & Malloy Ltd.
RTI Biologics, Inc.
LandOfFree
Vascular graft sterilization and decellularization does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vascular graft sterilization and decellularization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vascular graft sterilization and decellularization will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4230225